Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03093116 |
|---|---|
| Brief Title: | A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1) |
| First Submitted : | March 6, 2017 |
| First Submitted that Met QC Criteria : | March 21, 2017 |
| First Posted : | March 28, 2017 |
| Last Update Submitted that Met QC Criteria : | February 5, 2024 |
| Last Update Posted : | February 7, 2024 |